Novo Nordisk has launched Extensior, South Africa's first authorised semaglutide copy, cheaper than Ozempic and pitched as widening access to diabetes care. But ...

Gold's richest run ever handed South Africa's mining majors record windfalls — AngloGold's earnings nearly tripled to $2.7bn, ...

Every so often a piece of private research does the rounds that's too good to keep private. James Gubb's note on AI ...

Listen here In this episode, we unpack the growing impeachment momentum against President Ramaphosa and its potential threat to the government of national unity ...

Former hedge fund manager and CFA James Gubb argues the AI boom is real, but many investors are backing the wrong winners. In this interview with Alec Hogg, he ...

By Adrian Ephraim Dopamine. It’s the brain’s in-house drug of choice; a neurotransmitter that deals in feelings of pleasure ...

Moonshot’s Kimi K3 has become the breakout star of China’s AI sector, drawing comparisons to DeepSeek and challenging assumptions about America’s lead in advanc ...

Fresh revelations from the Epstein files have intensified scrutiny of former Prince Andrew, raising questions about alleged misuse of royal influence, confident ...

Listen here In this episode of BizNews Daybreak, political commentator Solly Moeng examines South Africa’s deepening criminal ...

Listen here In this episode of BizNews Daybreak, we cover global strikes in the US-Iran conflict, Red Sea shipping risks, Paramount's blocked merger, and new UK ...

Listen here In April he told the country he was done, headed for the private sector. By July he'd changed his mind. Chris Pappas, the DA's rising star and mayor ...

Listen here In today's BizNews Daybreak we dive into Amazon's quiet maneuver past Starlink into South Africa's satellite ...